度伐利尤单抗对比阿替利珠单抗一线治疗广泛期小细胞肺癌的成本-效果分析
陈叶莉, 龙云春, 陈方, 陈煜
Cost-effectiveness analysis of durvalumab versus atezolizumab as a first-line treatment for extensive-stage small cell lung cancer
CHEN Yeli, LONG Yunchun, CHEN Fang, CHEN Yu
中国医院药学杂志
.
2024, (7): 815
-821
.
DOI: 10.13286/j.1001-5213.2024.07.11
